Celldex Therapeutics
CLDX
#4701
Rank
C$2.70 B
Marketcap
C$40.69
Share price
-0.51%
Change (1 day)
11.34%
Change (1 year)

Celldex Therapeutics (CLDX) - Total assets

Total assets on the balance sheet as of September 2025 : C$0.89 Billion

According to Celldex Therapeutics's latest financial reports the company's total assets are C$0.89 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Celldex Therapeutics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31C$1.13 B84.1%
2023-12-31C$0.61 B29.03%
2022-12-31C$0.47 B-15.54%
2021-12-31C$0.56 B88.45%
2020-12-31C$0.30 B87.29%
2019-12-31C$0.16 B-24.35%
2018-12-31C$0.21 B-46.51%
2017-12-31C$0.39 B-22.97%
2016-12-31C$0.51 B10.01%
2015-12-31C$0.46 B62.71%
2014-12-31C$0.28 B-22.1%
2013-12-31C$0.36 B195.97%
2012-12-31C$0.12 B25.24%
2011-12-31C$99.67 M-9.3%
2010-12-31C$0.10 B-25.59%
2009-12-31C$0.14 B74.04%
2008-12-31C$84.86 M807.41%
2007-12-31C$9.35 M-86.94%
2006-12-31C$71.58 M68.67%
2005-12-31C$42.43 M-22.86%
2004-12-31C$55.01 M35.47%
2003-12-31C$40.6 M-27.02%
2002-12-31C$55.64 M-34.69%
2001-12-31C$85.2 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Seagen
SGEN
C$5.02 B 460.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
C$0.32 B-63.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$2.01 B 125.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$124.52 B 13,801.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$288.36 B 32,089.77%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$113.91 B 12,616.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
C$4.21 M-99.53%๐Ÿ‡บ๐Ÿ‡ธ USA